235 related articles for article (PubMed ID: 22825578)
1. The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque.
Uslaner JM; Eddins D; Puri V; Cannon CE; Sutcliffe J; Chew CS; Pearson M; Vivian JA; Chang RK; Ray WJ; Kuduk SD; Wittmann M
Psychopharmacology (Berl); 2013 Jan; 225(1):21-30. PubMed ID: 22825578
[TBL] [Abstract][Full Text] [Related]
2. The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model.
Puri V; Wang X; Vardigan JD; Kuduk SD; Uslaner JM
Behav Brain Res; 2015; 287():96-9. PubMed ID: 25800972
[TBL] [Abstract][Full Text] [Related]
3. Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey.
Vardigan JD; Cannon CE; Puri V; Dancho M; Koser A; Wittmann M; Kuduk SD; Renger JJ; Uslaner JM
Psychopharmacology (Berl); 2015 Jun; 232(11):1859-66. PubMed ID: 25491927
[TBL] [Abstract][Full Text] [Related]
4. The M1 Muscarinic Positive Allosteric Modulator PQCA Improves Performance on Translatable Tests of Memory and Attention in Rhesus Monkeys.
Lange HS; Cannon CE; Drott JT; Kuduk SD; Uslaner JM
J Pharmacol Exp Ther; 2015 Dec; 355(3):442-50. PubMed ID: 26446308
[TBL] [Abstract][Full Text] [Related]
5. Preclinical to Human Translational Pharmacology of the Novel M
Uslaner JM; Kuduk SD; Wittmann M; Lange HS; Fox SV; Min C; Pajkovic N; Harris D; Cilissen C; Mahon C; Mostoller K; Warrington S; Beshore DC
J Pharmacol Exp Ther; 2018 Jun; 365(3):556-566. PubMed ID: 29563325
[TBL] [Abstract][Full Text] [Related]
6. TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys.
Kurimoto E; Nakashima M; Kimura H; Suzuki M
PLoS One; 2019; 14(3):e0207969. PubMed ID: 30856192
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Pharmacological Comparison of TAK-071, a Positive Allosteric Modulator of Muscarinic M
Mandai T; Kasahara M; Kurimoto E; Tanaka M; Suzuki M; Nakatani A; Kimura H
Neuroscience; 2019 Aug; 414():60-76. PubMed ID: 31299348
[TBL] [Abstract][Full Text] [Related]
8. Effects of a novel M4 muscarinic positive allosteric modulator on behavior and cognitive deficits relevant to Alzheimer's disease and schizophrenia in rhesus monkey.
Lange HS; Vardigan JD; Cannon CE; Puri V; Henze DA; Uslaner JM
Neuropharmacology; 2021 Oct; 197():108754. PubMed ID: 34389398
[TBL] [Abstract][Full Text] [Related]
9. Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease.
Melancon BJ; Tarr JC; Panarese JD; Wood MR; Lindsley CW
Drug Discov Today; 2013 Dec; 18(23-24):1185-99. PubMed ID: 24051397
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Characterization of the Novel and Selective
Wang X; Daley C; Gakhar V; Lange HS; Vardigan JD; Pearson M; Zhou X; Warren L; Miller CO; Belden M; Harvey AJ; Grishin AA; Coles CJ; O'Connor SM; Thomson F; Duffy JL; Bell IM; Uslaner JM
J Pharmacol Exp Ther; 2020 May; 373(2):311-324. PubMed ID: 32094294
[TBL] [Abstract][Full Text] [Related]
11. Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors.
Alt A; Pendri A; Bertekap RL; Li G; Benitex Y; Nophsker M; Rockwell KL; Burford NT; Sum CS; Chen J; Herbst JJ; Ferrante M; Hendricson A; Cvijic ME; Westphal RS; O'Connell J; Banks M; Zhang L; Gentles RG; Jenkins S; Loy J; Macor JE
J Pharmacol Exp Ther; 2016 Feb; 356(2):293-304. PubMed ID: 26582730
[TBL] [Abstract][Full Text] [Related]
12. An Approach to Discovering Novel Muscarinic M
Kurimoto E; Matsuda S; Shimizu Y; Sako Y; Mandai T; Sugimoto T; Sakamoto H; Kimura H
J Pharmacol Exp Ther; 2018 Jan; 364(1):28-37. PubMed ID: 29025977
[TBL] [Abstract][Full Text] [Related]
13. Progress toward a high-affinity allosteric enhancer at muscarinic M1 receptors.
Lazareno S; Popham A; Birdsall NJ
J Mol Neurosci; 2003; 20(3):363-7. PubMed ID: 14501021
[TBL] [Abstract][Full Text] [Related]
14. Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation.
Ma L; Seager MA; Wittmann M; Jacobson M; Bickel D; Burno M; Jones K; Graufelds VK; Xu G; Pearson M; McCampbell A; Gaspar R; Shughrue P; Danziger A; Regan C; Flick R; Pascarella D; Garson S; Doran S; Kreatsoulas C; Veng L; Lindsley CW; Shipe W; Kuduk S; Sur C; Kinney G; Seabrook GR; Ray WJ
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15950-5. PubMed ID: 19717450
[TBL] [Abstract][Full Text] [Related]
15. AF710B, a Novel M1/σ1 Agonist with Therapeutic Efficacy in Animal Models of Alzheimer’s Disease.
Fisher A; Bezprozvanny I; Wu L; Ryskamp DA; Bar-Ner N; Natan N; Brandeis R; Elkon H; Nahum V; Gershonov E; LaFerla FM; Medeiros R
Neurodegener Dis; 2016; 16(1-2):95-110. PubMed ID: 26606130
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous activation of mGlu
Cieślik P; Domin H; Chocyk A; Gruca P; Litwa E; Płoska A; Radulska A; Pelikant-Małecka I; Brański P; Kalinowski L; Wierońska JM
Neuropharmacology; 2020 Sep; 174():107866. PubMed ID: 31785263
[TBL] [Abstract][Full Text] [Related]
17. T-495, a novel low cooperative M
Mandai T; Sako Y; Kurimoto E; Shimizu Y; Nakamura M; Fushimi M; Maeda R; Miyamoto M; Kimura H
Pharmacol Res Perspect; 2020 Feb; 8(1):e00560. PubMed ID: 31990455
[TBL] [Abstract][Full Text] [Related]
18. 4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine Receptor.
Mistry SN; Jörg M; Lim H; Vinh NB; Sexton PM; Capuano B; Christopoulos A; Lane JR; Scammells PJ
J Med Chem; 2016 Jan; 59(1):388-409. PubMed ID: 26624844
[TBL] [Abstract][Full Text] [Related]
19. TAK-071, a novel M
Sako Y; Kurimoto E; Mandai T; Suzuki A; Tanaka M; Suzuki M; Shimizu Y; Yamada M; Kimura H
Neuropsychopharmacology; 2019 Apr; 44(5):950-960. PubMed ID: 30089885
[TBL] [Abstract][Full Text] [Related]
20. AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model.
Bradley SR; Lameh J; Ohrmund L; Son T; Bajpai A; Nguyen D; Friberg M; Burstein ES; Spalding TA; Ott TR; Schiffer HH; Tabatabaei A; McFarland K; Davis RE; Bonhaus DW
Neuropharmacology; 2010 Feb; 58(2):365-73. PubMed ID: 19835892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
